/

Batteries & E-Mobility

/

Novocure

Novocure

Novocure

Verified Nov 2026

Batteries & E-Mobility

·

Switzerland flag

Root, Lucerne

·

Since 2000

Novocure is a global oncology medical device company founded in 2000 that develops and commercializes Tumor Treating Fields therapy, a non-invasive platform using alternating electric fields to disrupt cancer cell division. Headquartered in Saint Helier, Jersey, with over 1,300 employees and revenues in the $500 million to $1 billion band, the company serves patients with aggressive solid tumors across North America, Europe, the Middle East, and Asia. Its marketed products include Optune Gio for glioblastoma and Optune Lua for malignant pleural mesothelioma, with recent expansion into pancreatic cancer treatment.

Novocure

Verified Nov 2026

AT A GLANCE

Founded

2000

Headquarters

Switzerland flag

Root, Lucerne

Employees

1,000-5,000

Ownership

Novocure at a glance

Revenue

$500M-1B

Est. band

Employees

1,000-5,000

Founded

2000

Headquarters

Root, Lucerne

Industries

Automotive

Electric Vehicles

Medical

Industrial Equipment

Overview

Novocure is a global oncology medical device company founded in 2000 that develops and commercializes Tumor Treating Fields therapy, a non-invasive platform using alternating electric fields to disrupt cancer cell division. Headquartered in Saint Helier, Jersey, with over 1,300 employees and revenues in the $500 million to $1 billion band, the company serves patients with aggressive solid tumors across North America, Europe, the Middle East, and Asia. Its marketed products include Optune Gio for glioblastoma and Optune Lua for malignant pleural mesothelioma, with recent expansion into pancreatic cancer treatment.

At a glance

Attribute

Detail

Founded

2000

Headquarters

Root, Lucerne

Employees

1,000-5,000

Revenue

$500M-1B (estimated)

Primary capability

Batteries & E-Mobility

What Novocure makes

Novocure offers two primary commercialized products, Optune Gio and Optune Lua, both designed for use alongside standard chemotherapy or other therapies in defined cancer indications.

Latest developments

Company details

The company operates as a private entity with over 1,300 employees and serves medical oncology and thoracic oncology sectors across multiple geographic regions. Novocure was founded in 2000, has an estimated 1,000-5,000 employees, and is headquartered in Root, Lucerne.

Frequently asked questions

What does Novocure make?

Novocure is a global oncology medical device company founded in 2000 that develops and commercializes Tumor Treating Fields therapy, a non-invasive platform using alternating electric fields to disrupt cancer cell division. Headquartered in Saint Helier, Jersey, with over 1,300 employees and revenues in the $500 million to $1 billion band, the company serves patients with aggressive solid tumors across North America, Europe, the Middle East, and Asia. Its marketed products include Optune Gio for glioblastoma and Optune Lua for malignant pleural mesothelioma, with recent expansion into pancreatic cancer treatment.

Where is Novocure headquartered?

Novocure is headquartered in Root, Lucerne.

When was Novocure founded?

Novocure was founded in 2000.

How big is Novocure?

Novocure has an estimated 1,000-5,000 employees, with revenue in the $500M-1B range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Root, Lucerne (HQ)Headquarters · Lucerne, Switzerland
Root, Lucerne (HQ)Root, Lucerne, SwitzerlandHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.